MR

Malti Rawal

Active Director Director DIN 06807819
DIN 06807819 First appointment Feb 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value •••• Premium profile

About Malti Rawal

Data last updated:

Malti Rawal is a Director at Albino Biochem Private Limited (since 2014). The company operates in Trading. Albino Biochem Private Limited reported revenue of ₹1.29 Cr (FY 2024).

DIN 06807819
Primary Designation Director
Industry Trading
First Appointment 20 Feb 2014
Oldest Company Age 12 yrs
Largest company Albino Biochem Private Limited · ₹1.29 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Albino Biochem Private Limited U24233MP2014PTC032414
Director20 Feb 20142014₹1.29 Cr (FY 2024)Active

Board colleagues of Malti Rawal

NameDINCompanyDesignation
Shailendra Rawal06807814Albino Biochem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Albino Biochem Private Limited
Premium access

Shareholding and investment profile for Malti Rawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Malti Rawal

Malti Rawal currently holds 1 directorship: Albino Biochem Private Limited (Director, since 20 Feb 2014, revenue ₹1.29 Cr (FY 2024)).

Malti Rawal was first appointed on 20 Feb 2014 as Director at Albino Biochem Private Limited.

The current boards of Malti Rawal's companies include Shailendra Rawal (Albino Biochem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available